accountPharmaceuticals won regulatory approval on Monday for a new hepatitis C drug, setting off a marketing battle with Merck over new drugs that are expected to improve the cure rate of the viral disease and shorten the treatment duration. Incivek, as the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Second Entry Wins Approval as Hepatitis C Drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account